234 related articles for article (PubMed ID: 12467070)
1. A multicenter phase II study of the intravenous administration of liposomal tretinoin in patients with acquired immunodeficiency syndrome-associated Kaposi's sarcoma.
Bernstein ZP; Chanan-Khan A; Miller KC; Northfelt DW; Lopez-Berestein G; Gill PS
Cancer; 2002 Dec; 95(12):2555-61. PubMed ID: 12467070
[TBL] [Abstract][Full Text] [Related]
2. Multicenter trial of low-dose paclitaxel in patients with advanced AIDS-related Kaposi sarcoma.
Tulpule A; Groopman J; Saville MW; Harrington W; Friedman-Kien A; Espina BM; Garces C; Mantelle L; Mettinger K; Scadden DT; Gill PS
Cancer; 2002 Jul; 95(1):147-54. PubMed ID: 12115328
[TBL] [Abstract][Full Text] [Related]
3. All-trans retinoic acid for the treatment of AIDS-related Kaposi's sarcoma: results of a pilot phase II study.
Gill PS; Espina BM; Moudgil T; Kidane S; Esplin JA; Tulpule A; Levine AM
Leukemia; 1994; 8 Suppl 3():S26-32. PubMed ID: 7808021
[TBL] [Abstract][Full Text] [Related]
4. AIDS-related Kaposi's sarcoma: a phase II study of liposomal doxorubicin. The TLC D-99 Study Group.
Cheung TW; Remick SC; Azarnia N; Proper JA; Barrueco JR; Dezube BJ
Clin Cancer Res; 1999 Nov; 5(11):3432-7. PubMed ID: 10589755
[TBL] [Abstract][Full Text] [Related]
5. Population pharmacokinetics and pharmacodynamics of pegylated-liposomal doxorubicin in patients with AIDS-related Kaposi's sarcoma.
Amantea MA; Forrest A; Northfelt DW; Mamelok R
Clin Pharmacol Ther; 1997 Mar; 61(3):301-11. PubMed ID: 9084455
[TBL] [Abstract][Full Text] [Related]
6. Phase 1/2 trial of BMS-275291 in patients with human immunodeficiency virus-related Kaposi sarcoma: a multicenter trial of the AIDS Malignancy Consortium.
Brinker BT; Krown SE; Lee JY; Cesarman E; Chadburn A; Kaplan LD; Henry DH; Von Roenn JH
Cancer; 2008 Mar; 112(5):1083-8. PubMed ID: 18224669
[TBL] [Abstract][Full Text] [Related]
7. A randomized, double-blind study of pegylated liposomal doxorubicin for the treatment of AIDS-related Kaposi's sarcoma.
Cooley T; Henry D; Tonda M; Sun S; O'Connell M; Rackoff W
Oncologist; 2007 Jan; 12(1):114-23. PubMed ID: 17227906
[TBL] [Abstract][Full Text] [Related]
8. Weekly oral etoposide in patients with Kaposi's sarcoma associated with human immunodeficiency virus infection: a phase I multicenter trial of the AIDS Clinical Trials Group.
Paredes J; Kahn JO; Tong WP; Feldstein ML; Lin S; Bennett JM; Metroka CE; Ratner L; Krown SE
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Jun; 9(2):138-44. PubMed ID: 7749790
[TBL] [Abstract][Full Text] [Related]
9. The effects of preparations of human chorionic gonadotropin on AIDS-related Kaposi's sarcoma.
Gill PS; Lunardi-Ishkandar Y; Louie S; Tulpule A; Zheng T; Espina BM; Besnier JM; Hermans P; Levine AM; Bryant JL; Gallo RC
N Engl J Med; 1996 Oct; 335(17):1261-9. PubMed ID: 8857005
[TBL] [Abstract][Full Text] [Related]
10. Continuous infusion etoposide in advanced AIDS-related kaposi sarcoma.
Remick SC; Reddy M; Ekman K; Vyzula R; Hilstro J; Horton J
J Infus Chemother; 1996; 6(2):92-6. PubMed ID: 8809657
[TBL] [Abstract][Full Text] [Related]
11. Randomized phase II trial of matrix metalloproteinase inhibitor COL-3 in AIDS-related Kaposi's sarcoma: an AIDS Malignancy Consortium Study.
Dezube BJ; Krown SE; Lee JY; Bauer KS; Aboulafia DM
J Clin Oncol; 2006 Mar; 24(9):1389-94. PubMed ID: 16549833
[TBL] [Abstract][Full Text] [Related]
12. Weekly docetaxel is safe and effective in the treatment of advanced-stage acquired immunodeficiency syndrome-related Kaposi sarcoma.
Lim ST; Tupule A; Espina BM; Levine AM
Cancer; 2005 Jan; 103(2):417-21. PubMed ID: 15578686
[TBL] [Abstract][Full Text] [Related]
13. Treatment of recurrent Kaposi's sarcoma of an AIDS patient with weekly paclitaxel.
Hsu CH; Chen MY; Cheng AL
Anticancer Res; 2000; 20(2B):1159-61. PubMed ID: 10810414
[TBL] [Abstract][Full Text] [Related]
14. Extravasation of liposomal daunorubicin in patients with AIDS-associated Kaposi's sarcoma: a report of four cases.
Cabriales S; Bresnahan J; Testa D; Espina BM; Scadden DT; Ross M; Gill PS
Oncol Nurs Forum; 1998; 25(1):67-70. PubMed ID: 9460774
[TBL] [Abstract][Full Text] [Related]
15. Liposomal doxorubicin: new preparation. Useful in Kaposi's sarcoma.
Prescrire Int; 1998 Jun; 7(35):69-70. PubMed ID: 10342919
[TBL] [Abstract][Full Text] [Related]
16. The effect of HAART in 254 consecutive patients with AIDS-related Kaposi's sarcoma.
Bower M; Weir J; Francis N; Newsom-Davis T; Powles S; Crook T; Boffito M; Gazzard B; Nelson M
AIDS; 2009 Aug; 23(13):1701-6. PubMed ID: 19550283
[TBL] [Abstract][Full Text] [Related]
17. Angiogenesis inhibitor IM862 is ineffective against AIDS-Kaposi's sarcoma in a phase III trial, but demonstrates sustained, potent effect of highly active antiretroviral therapy: from the AIDS Malignancy Consortium and IM862 Study Team.
Noy A; Scadden DT; Lee J; Dezube BJ; Aboulafia D; Tulpule A; Walmsley S; Gill P
J Clin Oncol; 2005 Feb; 23(5):990-8. PubMed ID: 15598977
[TBL] [Abstract][Full Text] [Related]
18. [The value of conventionally fractionated radiotherapy in the local treatment of HIV-related Kaposi's sarcoma].
Saran F; Adamietz IA; Mose S; Thilmann C; Böttcher HD
Strahlenther Onkol; 1995 Oct; 171(10):594-9. PubMed ID: 8571179
[TBL] [Abstract][Full Text] [Related]
19. Liposomal chemotherapies.
Smart T
GMHC Treat Issues; 1995; 9(7/8):13. PubMed ID: 11362653
[TBL] [Abstract][Full Text] [Related]
20. Bendamustine hydrochloride in patients with refractory soft tissue sarcoma: a noncomparative multicenter phase 2 study of the German sarcoma group (AIO-001).
Hartmann JT; Mayer F; Schleicher J; Horger M; Huober J; Meisinger I; Pintoffl J; Käfer G; Kanz L; Grünwald V;
Cancer; 2007 Aug; 110(4):861-6. PubMed ID: 17599772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
